Brief: Hofseth Biocare Q4 Operational Loss Widens To NOK 18.7 Mln

Hofseth Biocare ASA

08/02/2019 16:04

Feb 8 (Reuters) - Hofseth Biocare ASA  HOFBC.OL :
    * OPERATING REVENUES OF NOK 14.3M (26.4M) IN Q4 OF 2018
    * OPERATIONAL PROFIT (EBITDA) FOR Q4 2018 WAS NEGATIVE NOK 18.7M (11.8M)
    * EXPECTS PROCESSED RAW MATERIAL TO CONTINUE INCREASING IN 2019
    * SEVERAL PATENTS AND TRADEMARKS FILED, AND NEW IMPORTANT IPR JURISDICTIONS EXPECTED IN NEAR
FUTURE
    * SEES CONTINUED PRODUCT DEVELOPMENT ON FINISHED PRODUCTS TO HAVE POSITIVE EFFECTS ON
RESULTS
GOING FORWARD
    * TO CONTINUE TO INCREASE AVERAGE PRICE MIX ON OMEGO, WITH HIGHER SALES OF SALMON OIL TO
PETS AND
HUMAN NUTRITION

Source text for Eikon:  ID:nGNE9bjKCp 
Further company coverage:  HOFBC.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))